| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conscious Sedation | 40 | 2020 | 528 | 9.100 |
Why?
|
| Dexmedetomidine | 22 | 2021 | 315 | 6.710 |
Why?
|
| Hypnotics and Sedatives | 36 | 2021 | 1162 | 5.650 |
Why?
|
| Pentobarbital | 10 | 2011 | 155 | 2.050 |
Why?
|
| Deep Sedation | 5 | 2021 | 121 | 1.900 |
Why?
|
| Propofol | 5 | 2021 | 629 | 1.210 |
Why?
|
| Anesthesia Recovery Period | 4 | 2017 | 157 | 1.180 |
Why?
|
| Anesthesia | 7 | 2020 | 1561 | 1.170 |
Why?
|
| Bradycardia | 4 | 2014 | 307 | 0.890 |
Why?
|
| Pediatrics | 8 | 2019 | 3475 | 0.880 |
Why?
|
| Anesthesia, Dental | 2 | 2019 | 67 | 0.790 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2011 | 177 | 0.710 |
Why?
|
| Child, Preschool | 38 | 2019 | 41005 | 0.670 |
Why?
|
| Hemodynamics | 7 | 2020 | 4196 | 0.660 |
Why?
|
| Adjuvants, Anesthesia | 3 | 2009 | 57 | 0.650 |
Why?
|
| Anesthesiology | 5 | 2018 | 1060 | 0.650 |
Why?
|
| Midazolam | 3 | 2013 | 270 | 0.630 |
Why?
|
| Hypotension | 3 | 2014 | 884 | 0.630 |
Why?
|
| Tomography, X-Ray Computed | 15 | 2015 | 20130 | 0.630 |
Why?
|
| Child | 45 | 2021 | 77709 | 0.600 |
Why?
|
| Sclerotherapy | 3 | 2004 | 175 | 0.580 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2018 | 455 | 0.580 |
Why?
|
| Anesthesia, General | 5 | 2017 | 1171 | 0.570 |
Why?
|
| Patient Discharge | 4 | 2018 | 3318 | 0.550 |
Why?
|
| Infant | 34 | 2019 | 35134 | 0.550 |
Why?
|
| Ketamine | 4 | 2016 | 501 | 0.540 |
Why?
|
| Expert Testimony | 1 | 2018 | 356 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2016 | 35425 | 0.530 |
Why?
|
| Administration, Intranasal | 2 | 2015 | 446 | 0.530 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2015 | 366 | 0.520 |
Why?
|
| Injections, Intramuscular | 3 | 2012 | 552 | 0.520 |
Why?
|
| Heart Rate | 5 | 2014 | 4092 | 0.500 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2014 | 110 | 0.470 |
Why?
|
| Anesthetics, Dissociative | 2 | 2016 | 80 | 0.460 |
Why?
|
| Analgesia | 1 | 2018 | 461 | 0.460 |
Why?
|
| Radiology, Interventional | 3 | 2002 | 460 | 0.450 |
Why?
|
| Office Visits | 1 | 2017 | 598 | 0.450 |
Why?
|
| Anesthesia, Intravenous | 2 | 2012 | 130 | 0.440 |
Why?
|
| Infusions, Intravenous | 8 | 2015 | 2274 | 0.430 |
Why?
|
| Anesthetics, Intravenous | 2 | 2013 | 417 | 0.430 |
Why?
|
| Respiration | 2 | 2012 | 1653 | 0.420 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 3 | 2012 | 469 | 0.410 |
Why?
|
| Speech | 1 | 2016 | 541 | 0.400 |
Why?
|
| Cardiovascular System | 2 | 2011 | 831 | 0.390 |
Why?
|
| Morphine | 1 | 2015 | 657 | 0.390 |
Why?
|
| Akathisia, Drug-Induced | 1 | 2011 | 67 | 0.380 |
Why?
|
| Diagnostic Imaging | 5 | 2009 | 3508 | 0.380 |
Why?
|
| Pattern Recognition, Visual | 1 | 2016 | 824 | 0.370 |
Why?
|
| Terminology as Topic | 3 | 2017 | 1547 | 0.370 |
Why?
|
| Chloral Hydrate | 3 | 2005 | 29 | 0.370 |
Why?
|
| Electroencephalography | 3 | 2012 | 6151 | 0.370 |
Why?
|
| Fluid Therapy | 1 | 2014 | 593 | 0.360 |
Why?
|
| Tracheobronchomalacia | 1 | 2012 | 131 | 0.360 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2012 | 392 | 0.350 |
Why?
|
| Glycopyrrolate | 1 | 2009 | 33 | 0.340 |
Why?
|
| Politics | 1 | 2014 | 791 | 0.310 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2010 | 306 | 0.300 |
Why?
|
| Respiration Disorders | 1 | 2011 | 371 | 0.300 |
Why?
|
| Drug Delivery Systems | 3 | 2019 | 2219 | 0.300 |
Why?
|
| Angiography | 1 | 2013 | 1639 | 0.290 |
Why?
|
| Humans | 73 | 2021 | 744366 | 0.290 |
Why?
|
| Artifacts | 2 | 2013 | 1904 | 0.290 |
Why?
|
| Memory | 1 | 2017 | 2174 | 0.290 |
Why?
|
| Monitoring, Physiologic | 5 | 2019 | 1739 | 0.290 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 1265 | 0.280 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 952 | 0.270 |
Why?
|
| Infant, Newborn | 14 | 2019 | 25628 | 0.260 |
Why?
|
| Adolescent | 22 | 2019 | 85779 | 0.260 |
Why?
|
| Endpoint Determination | 2 | 2018 | 601 | 0.250 |
Why?
|
| Anti-Anxiety Agents | 2 | 2019 | 390 | 0.250 |
Why?
|
| Fasting | 3 | 2020 | 1592 | 0.250 |
Why?
|
| Fentanyl | 2 | 2005 | 409 | 0.240 |
Why?
|
| Blood Pressure | 5 | 2014 | 8551 | 0.240 |
Why?
|
| Ethanol | 4 | 2009 | 1342 | 0.240 |
Why?
|
| Sclerosing Solutions | 1 | 2004 | 78 | 0.240 |
Why?
|
| Radiography, Interventional | 2 | 2009 | 1095 | 0.240 |
Why?
|
| Pulmonary Ventilation | 2 | 2011 | 374 | 0.230 |
Why?
|
| Laparoscopy | 1 | 2015 | 2150 | 0.230 |
Why?
|
| Capnography | 2 | 2003 | 89 | 0.230 |
Why?
|
| Consensus | 6 | 2020 | 2960 | 0.230 |
Why?
|
| Male | 39 | 2017 | 350115 | 0.220 |
Why?
|
| Female | 38 | 2017 | 380193 | 0.200 |
Why?
|
| Aerosols | 2 | 2015 | 625 | 0.200 |
Why?
|
| Hypertension | 3 | 2013 | 8479 | 0.200 |
Why?
|
| Pilot Projects | 5 | 2015 | 8319 | 0.200 |
Why?
|
| Guidelines as Topic | 3 | 2013 | 1405 | 0.200 |
Why?
|
| Congenital Hypothyroidism | 1 | 2001 | 39 | 0.190 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 1486 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2009 | 1253 | 0.190 |
Why?
|
| Dental Offices | 1 | 2019 | 13 | 0.170 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2000 | 129 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 3677 | 0.170 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 1150 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 10943 | 0.170 |
Why?
|
| Embolization, Therapeutic | 3 | 2009 | 1392 | 0.170 |
Why?
|
| Blood Coagulation Disorders | 1 | 2001 | 337 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 1637 | 0.160 |
Why?
|
| Patient Escort Service | 1 | 2017 | 1 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2009 | 2148 | 0.150 |
Why?
|
| Preoperative Care | 2 | 2011 | 2251 | 0.150 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 7914 | 0.150 |
Why?
|
| Injections, Intravenous | 3 | 2006 | 1420 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2017 | 5077 | 0.150 |
Why?
|
| Prospective Studies | 11 | 2021 | 53290 | 0.150 |
Why?
|
| Perioperative Care | 2 | 2015 | 1002 | 0.150 |
Why?
|
| Arteriovenous Malformations | 1 | 2000 | 396 | 0.150 |
Why?
|
| Credentialing | 2 | 2011 | 126 | 0.150 |
Why?
|
| Biopsy | 1 | 2009 | 6755 | 0.150 |
Why?
|
| Sleep Stages | 2 | 2012 | 686 | 0.150 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 1438 | 0.140 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6234 | 0.140 |
Why?
|
| Respiratory Mechanics | 2 | 2011 | 686 | 0.140 |
Why?
|
| Respiratory Aspiration | 1 | 2017 | 81 | 0.140 |
Why?
|
| Patient Selection | 1 | 2008 | 4216 | 0.130 |
Why?
|
| Hemangioma | 1 | 2001 | 738 | 0.130 |
Why?
|
| Insurance, Health | 1 | 2008 | 2494 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2004 | 1161 | 0.130 |
Why?
|
| Premedication | 1 | 2015 | 258 | 0.120 |
Why?
|
| Amnesia | 1 | 2016 | 248 | 0.120 |
Why?
|
| Reference Standards | 1 | 2017 | 1025 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3508 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2017 | 775 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2002 | 2488 | 0.110 |
Why?
|
| Quality Improvement | 2 | 2019 | 3749 | 0.110 |
Why?
|
| United States Food and Drug Administration | 2 | 2012 | 1584 | 0.110 |
Why?
|
| Anesthesia, Conduction | 1 | 2015 | 238 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 957 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 674 | 0.100 |
Why?
|
| Airway Management | 1 | 2015 | 329 | 0.100 |
Why?
|
| Rage | 1 | 2011 | 30 | 0.100 |
Why?
|
| Oxygen | 3 | 2009 | 4189 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 426 | 0.090 |
Why?
|
| Checklist | 1 | 2017 | 833 | 0.090 |
Why?
|
| Treatment Outcome | 9 | 2018 | 63107 | 0.090 |
Why?
|
| Mediastinum | 2 | 2008 | 267 | 0.090 |
Why?
|
| Peripheral Nervous System | 1 | 2011 | 150 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2016 | 1101 | 0.090 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1198 | 0.090 |
Why?
|
| Age Factors | 4 | 2013 | 18373 | 0.090 |
Why?
|
| Hospitals, Community | 1 | 2012 | 347 | 0.090 |
Why?
|
| Cardiac Output | 1 | 2011 | 854 | 0.080 |
Why?
|
| Research | 1 | 2017 | 1999 | 0.080 |
Why?
|
| Klinefelter Syndrome | 1 | 2009 | 48 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2887 | 0.080 |
Why?
|
| Contrast Media | 4 | 2013 | 5300 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2014 | 77460 | 0.080 |
Why?
|
| Sleep | 2 | 2016 | 4622 | 0.080 |
Why?
|
| Body Weight | 2 | 2013 | 4671 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2011 | 936 | 0.080 |
Why?
|
| Computers | 1 | 2011 | 612 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2212 | 0.080 |
Why?
|
| Tomography, Emission-Computed | 1 | 2011 | 1144 | 0.080 |
Why?
|
| Tracheomalacia | 1 | 2008 | 63 | 0.080 |
Why?
|
| Administration, Oral | 3 | 2004 | 3914 | 0.080 |
Why?
|
| Research Design | 2 | 2018 | 5984 | 0.080 |
Why?
|
| Time Factors | 4 | 2016 | 40075 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.080 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 7658 | 0.080 |
Why?
|
| Touch | 1 | 2010 | 306 | 0.080 |
Why?
|
| Anesthetics | 1 | 2013 | 539 | 0.080 |
Why?
|
| Insurance Claim Reporting | 1 | 2008 | 163 | 0.080 |
Why?
|
| Current Procedural Terminology | 1 | 2008 | 92 | 0.080 |
Why?
|
| Radiology Department, Hospital | 2 | 2002 | 412 | 0.070 |
Why?
|
| Tracheal Diseases | 1 | 2007 | 113 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2013 | 1461 | 0.070 |
Why?
|
| Caregivers | 1 | 2018 | 2095 | 0.070 |
Why?
|
| Positive-Pressure Respiration | 1 | 2011 | 633 | 0.070 |
Why?
|
| World Health Organization | 1 | 2012 | 1318 | 0.070 |
Why?
|
| Wakefulness | 1 | 2013 | 1245 | 0.070 |
Why?
|
| Movement | 1 | 2013 | 1471 | 0.070 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 1216 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 1643 | 0.070 |
Why?
|
| Adult | 8 | 2021 | 214052 | 0.060 |
Why?
|
| Boston | 2 | 2011 | 9312 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 4253 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2010 | 7730 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2016 | 2708 | 0.060 |
Why?
|
| Logistic Models | 2 | 2013 | 13409 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2011 | 1487 | 0.060 |
Why?
|
| Craniosynostoses | 1 | 2009 | 401 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 15078 | 0.060 |
Why?
|
| Linear Models | 2 | 2008 | 5953 | 0.060 |
Why?
|
| Anxiety | 1 | 2019 | 4293 | 0.060 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 2002 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2011 | 1357 | 0.060 |
Why?
|
| Young Adult | 3 | 2015 | 56429 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2009 | 570 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6994 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2004 | 276 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2971 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2014 | 2921 | 0.060 |
Why?
|
| Equipment Design | 1 | 2011 | 3582 | 0.060 |
Why?
|
| Organization and Administration | 1 | 2002 | 52 | 0.060 |
Why?
|
| Vascular Malformations | 1 | 2008 | 454 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2009 | 1125 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6366 | 0.050 |
Why?
|
| Nursing Assessment | 1 | 2002 | 107 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2004 | 323 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2291 | 0.050 |
Why?
|
| Sodium Tetradecyl Sulfate | 1 | 2001 | 14 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 1534 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2002 | 81 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2014 | 5006 | 0.050 |
Why?
|
| Pediatric Nursing | 1 | 2002 | 103 | 0.050 |
Why?
|
| Tidal Volume | 1 | 2003 | 490 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 1084 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3309 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2014 | 3208 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 19905 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2004 | 345 | 0.050 |
Why?
|
| Tuberous Sclerosis | 1 | 2009 | 1029 | 0.050 |
Why?
|
| Fetal Hemoglobin | 2 | 1982 | 341 | 0.050 |
Why?
|
| Safety | 1 | 2004 | 1186 | 0.040 |
Why?
|
| Kidney | 1 | 2015 | 7184 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2001 | 494 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.040 |
Why?
|
| ROC Curve | 1 | 2006 | 3528 | 0.040 |
Why?
|
| Laparotomy | 1 | 2001 | 473 | 0.040 |
Why?
|
| Patient Care Team | 2 | 2016 | 2531 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2008 | 7282 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2010 | 3743 | 0.040 |
Why?
|
| Nasal Cavity | 1 | 2000 | 313 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2000 | 1005 | 0.040 |
Why?
|
| District of Columbia | 1 | 2017 | 157 | 0.040 |
Why?
|
| Seizures | 1 | 2009 | 2859 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 2 | 1982 | 1020 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 779 | 0.040 |
Why?
|
| United States | 3 | 2012 | 69872 | 0.030 |
Why?
|
| Algorithms | 2 | 2019 | 13882 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2001 | 594 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2001 | 658 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2005 | 1887 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 23336 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2003 | 1775 | 0.030 |
Why?
|
| Catheterization | 1 | 2000 | 1470 | 0.030 |
Why?
|
| Radiology | 1 | 2008 | 2099 | 0.030 |
Why?
|
| Sex Factors | 2 | 2004 | 10400 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6489 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12025 | 0.030 |
Why?
|
| Bronchoscopy | 2 | 2008 | 862 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 764 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 72296 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2008 | 1184 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 8664 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2265 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 8861 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 40559 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 213390 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14723 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3395 | 0.020 |
Why?
|
| Incidence | 1 | 1999 | 20952 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 39052 | 0.010 |
Why?
|
| Oximetry | 1 | 2003 | 471 | 0.010 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1978 | 125 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 15221 | 0.010 |
Why?
|
| Hemoglobin A2 | 1 | 1978 | 5 | 0.000 |
Why?
|
| West Indies | 1 | 1978 | 34 | 0.000 |
Why?
|
| Erythrocyte Count | 1 | 1978 | 163 | 0.000 |
Why?
|
| Hemoglobin, Sickle | 1 | 1978 | 122 | 0.000 |
Why?
|
| Homozygote | 1 | 1978 | 1787 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1978 | 6459 | 0.000 |
Why?
|
| Aged | 1 | 1978 | 163288 | 0.000 |
Why?
|